Clinical Research Studies

Peter J. Holland, MD, FACOEM, DFAPA, Associate Professor of Clinical Biomedical Science

Dr. Holland is a principal investigator of both investigator-initiated and industry-sponsored pharmaceutical trials. Since 1981, he has completed more than 60 double-blind, controlled clinical trials. Indications have included all major psychiatric diagnoses; however, his primary areas of interest are mood disorders, anxiety disorders, sleep and dementia, including Alzheimer’s disease. Dr. Holland directed his own clinical and research practice in Boca Raton for twenty-five years. For the last nine years, he has conducted clinical research trials at FAU, first at the Louis and Anne Green Memory and Wellness Center and now at FAU's Charles E. Schmidt College of Medicine.

Research Staff:

Tracey Thomas, M.Ed., Ed.S., Study Coordinator and Rater
Lori Fisher, M.A., Study Coordinator and Rater
Anna Lisa Curtis, B.A., Study Coordinator and Rater
Mary Lou Riccio, M.Ed., Research Administrator

Telephone: 561-297-0164 

Current Studies:

Study of the safety and effectiveness of Immune Globulin Intravenous (Human) 10% Solution (IGIV 10%) for the treatment of Mild to Moderate Alzheimer’s Disease (Enrolling)
A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (Enrollment Closed)
Effect of LY2062430 on the Progression of Alzheimer's Disease (Enrollment Closed)
Continued Safety Monitoring of Solanezumab in Alzheimer's Disease (Enrollment Closed)

Treatment to prolong safe driving in early Alzheimer's (Enrollment Closed)